MGTX News & Analysis

2 articles

Market Mood

1 Bullish1 Neutral0 Bearish
MeiraGTx (MGTX) Insider Sold 27,659 Shares at $14.80 Each
EarningsNeutral7/12/2026

MeiraGTx (MGTX) Insider Sold 27,659 Shares at $14.80 Each

Stuart Naylor, Chief Scientific Officer of MeiraGTx Holdings plc (MGTX), sold 27,659 shares on July 7, 2026, with prices ranging from $13.36 to $15.33, averaging $14.80 per share. This sale, representing a 4% reduction in his holdings, aligns with a pre-scheduled Rule 10b5-1 trading plan. Naylor retains 641,000 shares, valued at $9.39 million based on the closing price of $14.66. MeiraGTx has seen a 89% stock appreciation over the past year, indicating strong investor confidence, which is crucial for market sentiment regarding biotech investments.

Read More: MeiraGTx (MGTX) Insider Sold 27,659 Shares at $14.80 Each
MeiraGTx Holdings (MGTX) Reaches 52-Week High at 13.72 USD
MarketsBullish7/2/2026

MeiraGTx Holdings (MGTX) Reaches 52-Week High at 13.72 USD

MeiraGTx Holdings (MGTX) reached a 52-week high of 13.72 USD. This milestone reflects a significant price movement for the stock, indicating positive market sentiment. The achievement of this high is relevant as it may influence investor confidence and trading activity. Continued upward movement could lead to increased investment interest in MGTX, impacting its market position.

Read More: MeiraGTx Holdings (MGTX) Reaches 52-Week High at 13.72 USD